Future growth expectations in earnings/operating earnings/profits/EPS?

Company targets to sustain or slightly improve margins for FY '24; expects better performance in Q3 and Q4. Goal to achieve 12% EBITDA margin in FY '25 driven by new high-margin product, MiEcoPET. Operating margin improved to about 10.5% in Q3 FY '24 with 300+ bps rise due to cost control. Net profit margin increased to 4.33% with a 75.95% rise in net profit in Q3 FY '24. Company anticipates growth driven by product innovation, sustainability initiatives, and expansion of its customer base. Plans to expand commercialization of MiEcoPET container starting Q1 FY '25 expected to positively impact

Any current/future new fundraising through debt or equity?

Mitsu Chem Plast Limited is currently raising funds through a rights issue priced at INR144 per share, with a ratio of 1 right share for every 8 shares held. The total planned fundraise from the rights issue is INR21.73 crores. Out of the raised funds, approximately INR15 crores will be used for debt repayment, and the remaining will support reserves and working capital. There is no immediate planned capital expenditure; the company will decide on expansion after the funds are raised. Post rights issue, the company expects a reduction in bank finance and overall finance costs starting Q1 2025.

Any current/future capex/capital investment/strategic investment?

Currently, there is no immediate capital expenditure (capex) planned. The company is in expansion mode and is considering future capex once funds from the ongoing rights issue are available. The rights issue (approx. INR21.73 crores) proceeds will partly repay debt and partly be used for reserves, working capital, and future expansion. Mitsu Chem Plast is also continuously investing in research and development, which is funded separately and ongoing. Backward integration for plastic recycling is being considered, but no immediate plans; currently, recycled materials are procured externally. Di

Future growth expectations in sales/revenue/volumes?

Mitsu Chem Plast expects improved sales and revenue growth in FY '25 compared to FY '24, with Q3 and Q4 of FY '24 showing positive momentum. The company aims to reach around INR 500 crores in topline by fully utilizing its current capacity of 25,000 tons per annum. Expansion plans are underway, potentially scaling towards INR 1,000 crores in the coming years, though specifics will be announced in future calls. Growth drivers include new sustainable product launches like MiEcoPET, targeting industries such as lube oil, edible oil, and FMCG. The company focuses on both existing large clients and

Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention the current or expected order book or pending orders for Mitsu Chem Plast Limited. However, it is noted that the company has resumed supplies to domestic and export-related clients after disruptions caused by lockdowns and global issues. There are many inquiries, especially for the hospital furniture segment and the new MiEcoPET product, which is under trial with clients in edible oil, lube oil, and FMCG industries. The company expects demand to improve significantly in Q3 and Q4 FY '24 and is optimistic about growth in FY '25. Mitsu Chem Plast has ad

IN US

Mitsu Chem PlastQ4 FY24Industrial Products

Mitsu Chem Plast Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹155P/E: 13.4Market Cap: ₹211 CrSector: Industrial Products

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→Mitsu Chem Plast expects improved sales and revenue growth in FY '25 compared to FY '24, with Q3 and Q4 of FY '24 showing positive momentum.
→The company aims to reach around INR 500 crores in topline by fully utilizing its current capacity of 25,000 tons per annum.
→Expansion plans are underway, potentially scaling towards INR 1,000 crores in the coming years, though specifics will be announced in future calls.
→Growth drivers include new sustainable product launches like MiEcoPET, targeting industries such as lube oil, edible oil, and FMCG.
→The company focuses on both existing large clients and adding new clients for business scaling.
→Export markets, especially with hospital furniture, are being explored for growth.
→Strategic initiatives include cost control, sustainability, and innovation to improve margins and volume.
→Overall, Mitsu anticipates stronger performance in FY '25 with continued expansion and capacity utilization improvements.

Margin guidance

Category 3

→Company targets to sustain or slightly improve margins for FY '24; expects better performance in Q3 and Q4.
→Goal to achieve 12% EBITDA margin in FY '25 driven by new high-margin product, MiEcoPET.
→Operating margin improved to about 10.5% in Q3 FY '24 with 300+ bps rise due to cost control.
→Net profit margin increased to 4.33% with a 75.95% rise in net profit in Q3 FY '24.
→Company anticipates growth driven by product innovation, sustainability initiatives, and expansion of its customer base.
→Plans to expand commercialization of MiEcoPET container starting Q1 FY '25 expected to positively impact earnings.
→Capacity utilization is about 85-87%, with potential to increase sales toward INR 500 crores from current ~300 crores.
→Debt repayment via rights issue will reduce finance cost, aiding profitability.
→Overall, FY '25 expected to show much better earnings and profitability.

3 more insights locked — sign up free to unlock

Fundraise plans

Yes

→Mitsu Chem Plast Limited is currently raising funds through a rights issue priced at INR144 per share, with a ratio of 1 right share for every 8 shares held.
→The total planned fundraise from the rights issue is INR21.73 crores.
→Out of the raised funds, approximately INR15 crores will be used for debt repayment, and the remaining will support reserves and working capital.
→There is no immediate planned capital expenditure; the company will decide on expansion after the funds are raised.
→Post rights issue, the company expects a reduction in bank finance and overall finance costs starting Q1 2025.
→No new debt fundraising is indicated; emphasis is on reducing existing debt via equity infusion.

Order book

→The transcript does not explicitly mention the current or expected order book or pending orders for Mitsu Chem Plast Limited.
→However, it is noted that the company has resumed supplies to domestic and export-related clients after disruptions caused by lockdowns and global issues.
→There are many inquiries, especially for the hospital furniture segment and the new MiEcoPET product, which is under trial with clients in edible oil, lube oil, and FMCG industries.
→The company expects demand to improve significantly in Q3 and Q4 FY '24 and is optimistic about growth in FY '25.
→Mitsu Chem Plast has added around 25 new clients recently, indicating ongoing order inflow and customer expansion.
→Flexibility in clientele allows switching between export and local supply based on market dynamics.
→Overall, while explicit order book figures are not disclosed, positive demand prospects and new client additions reflect a healthy order pipeline.

Capex plans

Yes

→Currently, there is no immediate capital expenditure (capex) planned.
→The company is in expansion mode and is considering future capex once funds from the ongoing rights issue are available.
→The rights issue (approx. INR21.73 crores) proceeds will partly repay debt and partly be used for reserves, working capital, and future expansion.
→Mitsu Chem Plast is also continuously investing in research and development, which is funded separately and ongoing.
→Backward integration for plastic recycling is being considered, but no immediate plans; currently, recycled materials are procured externally.
→Discussions about capacity expansion and strategic investments are expected to be announced in upcoming calls/updates.
→New product innovation such as MiEcoPET reflects strategic investment in sustainable packaging.

How does Mitsu Chem Plast rank vs peers in Industrial Products?

Pro feature

1Mitsu Chem Plast

Rev 3Mar 3

See full Industrial Products sector rankings

Want more stocks like Mitsu Chem Plast?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio